| Notice of Special Interest—Administrative Supplements to Advance Precision Medicine Using the All of Us Research Programs Data- NOT-PM-22-002 |
Supp
|
May 20, 2022 |
July 06, 2022 |
| Notice of Special Interest (NOSI)—Administrative Supplements for NIAID Regional Biocontainment Laboratories (RBL) and other NIH Grantees Conducting Research at RBL-affiliated Sites- NOT-AI-22-049 |
Supp
|
May 04, 2022 |
June 01, 2022 |
| Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy- NOT-CA-22-063 |
Multiple |
May 03, 2022 |
July 05, 2024 |
| Notice of Special Interest (NOSI)— Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP) - NOT-AI-22-042 |
R01
|
April 29, 2022 |
May 08, 2025 |
| Notice of Special Interest (NOSI)—Towards Developing a Cure for HBV in HIV/HBV Co-Infection - NOT-AI-22-043 |
R01, R41/R42, R21, R43/R44
|
April 29, 2022 |
May 08, 2025 |
| Notice of Special Interest (NOSI)—Administrative Supplements for Lyme Disease and other Tickborne Illnesses - NOT-AI-22-048 |
Supp
|
April 27, 2022 |
May 24, 2022 |
| Notice of Special Interest (NOSI)—Administrative Supplements for Research on Womens Health in the IDeA States- NOT-GM-22-005 |
Supp
|
April 06, 2022 |
October 18, 2024 |
| Notice of Special Interest (NOSI)— NIAID Administrative Supplement To Promote Discovery of Medical Countermeasures Against Chemical Threats - NOT-AI-22-030 |
Supp
|
March 02, 2022 |
March 02, 2024 |
| Notice of Special Interest (NOSI)—CCRP Administrative Supplement for Collaborative Science To Synergize Chemical Medical Countermeasures Discovery and Early Development - NOT-AI-22-029 |
Supp
|
February 25, 2022 |
March 02, 2024 |
| Notice of Special Interest (NOSI)—Optimizing Vascularized Composite Allograft Survival- NOT-AI-22-023 |
R21, R01
|
February 23, 2022 |
May 08, 2026 |
| Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection- NOT-HL-22-004 |
R01, R21
|
December 21, 2021 |
September 08, 2025 |
| Notice of Special Interest (NOSI)—Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities- NOT-MD-22-006 |
R01
|
December 21, 2021 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Advancing Research Needed to Develop a Universal Influenza Vaccine- NOT-AI-22-013 |
R01, R21
|
December 13, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional)- NOT-OD-22-030 |
Supp
|
December 02, 2021 |
January 27, 2023 |
| Notice of Special Interest (NOSI)—Research on the Health of Women of Understudied, Underrepresented, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)- NOT-OD-22-031 |
Supp
|
December 02, 2021 |
February 01, 2023 |
| Notice of Special Interest (NOSI)—Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional)- NOT-OD-22-032 |
Supp
|
December 02, 2021 |
February 01, 2024 |
| Notice of Special Interest (NOSI)—Accelerating Malaria Vaccine Discovery- NOT-AI-22-014 |
R01
|
December 01, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Molecular and Genetic Characterization of Inborn Errors of Immunity- NOT-AI-21-082 |
R01, R21
|
November 29, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Accelerating Progress in Celiac Disease Research- NOT-AI-22-004 |
Multiple |
November 23, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity- NOT-AI-21-072 |
R21
|
October 20, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes- NOT-AI-21-080 |
R21, R01
|
October 18, 2021 |
January 08, 2025 |
| Notice of Special Interest (NOSI)—Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp Clinical Trial Optional)- NOT-AI-21-074 |
Supp
|
September 24, 2021 |
September 24, 2024 |
| Notice of Special Interest (NOSI)—Immune Responses to Arthropod Feeding on Vertebrate Hosts- NOT-AI-21-059 |
R01, R21
|
July 29, 2021 |
September 08, 2024 |
| Notice of Special Interest (NOSI)—Using the Collaborative Cross (CC) Mouse Model for Immunoregulatory and Infectious Disease Research- NOT-AI-21-071 |
R01, R21
|
July 29, 2021 |
September 08, 2024 |
| Notice of Special Interest (NOSI)—Research Supplements To Promote Re-Entry and Re-Integration into Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed)- NOT-OD-21-134 |
Supp
|
July 23, 2021 |
October 07, 2023 |
